Holtec files for a Nasdaq IPO, betting the house on its SMR-300

Holtec publicly filed its registration statement with the SEC on July 10 for a proposed Nasdaq IPO. Founded in 1986, the company built its business on the unglamorous end of nuclear — spent-fuel storage, decommissioning shuttered plants — and is now running that arc in reverse: it restarted the Palisades plant in Michigan after a 2022 shutdown, and its S-1 pitches the 300MW SMR-300 as the core growth story, with roughly $400M in Department of Energy support toward building the first two units at the Palisades site.

Why it matters

The SMR IPO window is now processing companies with actual revenue. X-energy and Deep Fission listed earlier this year on development-stage stories; Holtec arrives with decades of nuclear-services cash flow plus the only US plant restart on its résumé — a different risk profile for public investors sizing the sector against the NRC's licensing overhaul and government-backed buildouts like Westinghouse's loan-supported program. A strong Holtec debut would reprice the whole "picks and shovels of the restart era" thesis; a weak one would say the market only pays for moonshots.

What to watch

The terms when the range is set (valuation vs. the pre-revenue SMR names), and construction milestones for the first SMR-300 units at Palisades — the proof the S-1's growth story depends on.